23-Valent Pneumococcal Polysaccharide Vaccine Market : Rising Trends with Top Countries Data, Technology and Business Outlook 2020 to 2026

The MarketWatch News Department was not involved in the creation of this content.

Sep 28, 2020 (The Expresswire) —
23-Valent Pneumococcal Polysaccharide Vaccine Market” is valued at 2058.1 million USD in 2020 is expected to reach 5330.9 million USD by the end of 2026, growing at a CAGR of 14.4% during 2021-2026, According to New Research Study. 360 Research Reports provides key analysis on the global market in a report, titled “23-Valent Pneumococcal Polysaccharide Vaccine Market by Types (Single Dose Vial, Pre-filled Syringe), Applications (For Children (2-10), For Person (10-64), For The Old (≥65)) and Region – Global Forecast to 2026” Browse Market data Tables and Figures spread through 93 Pages and in-depth TOC on 23-Valent Pneumococcal Polysaccharide Vaccine Market.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on

Read More